News

home News

[200424 저널 발표] Type I Interferon Response Drives Neuroinflammation and Synapse Loss in Alzheimer Disease

정선우 │ 2020-04-21

HIT

140

2020 Apr 1;130(4):1912-1930.
 doi: 10.1172/JCI133737.

Type I Interferon Response Drives Neuroinflammation and Synapse Loss in Alzheimer Disease

Abstract

Type I interferon (IFN) is a key cytokine that curbs viral infection and cell malignancy. Previously, we demonstrated a potent IFN immunogenicity of nucleic acid-containing (NA-containing) amyloid fibrils in the periphery. Here, we investigated whether IFN is associated with β-amyloidosis inside the brain and contributes to neuropathology. An IFN-stimulated gene (ISG) signature was detected in the brains of multiple murine Alzheimer disease (AD) models, a phenomenon also observed in WT mouse brain challenged with generic NA-containing amyloid fibrils. In vitro, microglia innately responded to NA-containing amyloid fibrils. In AD models, activated ISG-expressing microglia exclusively surrounded NA+ amyloid β plaques, which accumulated in an age-dependent manner. Brain administration of rIFN-β resulted in microglial activation and complement C3-dependent synapse elimination in vivo. Conversely, selective IFN receptor blockade effectively diminished the ongoing microgliosis and synapse loss in AD models. Moreover, we detected activated ISG-expressing microglia enveloping NA-containing neuritic plaques in postmortem brains of patients with AD. Gene expression interrogation revealed that IFN pathway was grossly upregulated in clinical AD and significantly correlated with disease severity and complement activation. Therefore, IFN constitutes a pivotal element within the neuroinflammatory network of AD and critically contributes to neuropathogenic processes.

Keywords: Alzheimer’s disease; Immunology; Innate immunity; Neuroscience; Synapses.




Prev [200424 저널발표] β-amyloid redirects norepinephrine signaling to activate the ...
Next [200508 저널발표] IL-33-PU.1 Transcriptome Reprogramming Drives Functional State...